Back to Search
DR. SUZANNE D CONZEN MD
MD
Medical Oncology Physician
NPI: 1518029073IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
036094337(IL)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
S5870(TX)
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 1987
Research & Publications (20)
Glucocorticoid receptor expression in breast cancer associates with older patient age.
PMID 18668364·Breast Cancer Res Treat·2009
8-other
Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues.
PMID 19383827·Clin Cancer Res·2009
4-observational
Adaptive variation regulates the expression of the human SGK1 gene in response to stress.
PMID 19461886·PLoS Genet·2009
8-other
Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation.
PMID 18780960·Phys Med Biol·2008
7-preclinical
Hsp90 regulates the phosphorylation and activity of serum- and glucocorticoid-regulated kinase-1.
PMID 18456663·J Biol Chem·2008
7-preclinical
Glucocorticoid (GC)-mediated down-regulation of urokinase plasminogen activator expression via the serum and GC regulated kinase-1/forkhead box O3a pathway.
PMID 18239069·Endocrinology·2008
4-observational
The MAP kinase phosphatase-1 MKP-1/DUSP1 is a regulator of human liver response to transplantation.
PMID 19032224·Am J Transplant·2008
8-other
Ubiquitin-proteasome degradation of serum- and glucocorticoid-regulated kinase-1 (SGK-1) is mediated by the chaperone-dependent E3 ligase CHIP.
PMID 16895519·Biochem J·2006
7-preclinical
Dexamethasone inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL induction.
PMID 17070682·Eur J Cancer·2006
8-other
A novel N-terminal hydrophobic motif mediates constitutive degradation of serum- and glucocorticoid-induced kinase-1 by the ubiquitin-proteasome pathway.
PMID 16817852·FEBS J·2006
7-preclinical
Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis.
PMID 16775428·Cancer Biol Ther·2006
7-preclinical
Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells.
PMID 16690749·Mol Endocrinol·2006
4-observational
In response to Dr. Formenti et al. (Int J Radiat Oncol Biol Phys 2005, 63:1275-1276).
PMID 16414377·Int J Radiat Oncol Biol Phys·2006
8-other
Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer.
PMID 16246546·Eur J Cancer·2005
8-other
A new dynamic Bayesian network (DBN) approach for identifying gene regulatory networks from time course microarray data.
PMID 15308537·Bioinformatics·2005
4-observational
Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
PMID 15590693·J Biol Chem·2005
8-other
Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials.
PMID 15752883·Int J Radiat Oncol Biol Phys·2005
3-trial
Mammary cancer and social interactions: identifying multiple environments that regulate gene expression throughout the life span.
PMID 15863708·J Gerontol B Psychol Sci Soc Sci·2005
6-review
Invariant p53 immunostaining in primary and recurrent breast cancer.
PMID 14687786·Eur J Cancer·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 180 HARVESTER DR STE 110
BURR RIDGE, IL 60527 - Phone
- (773) 834-4064
Quick Facts
- NPI
- 1518029073
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile